A Brief Review on Nanoparticles: Type of Platforms, Biological synthesis & Evaluation
Abstract
Nanoparticles refers to as particulate dispersions or solid particles with a size in the range of 10-1000nm. The nanoparticles have been used to alter the physical approach and improve the pharmacokinetic and pharmacodynamic properties of many type of drug molecules. They have significant advantages in conventional drug delivery in form of high specificity, high stability, high drug carrying capacity, control release ability, possibility occurs to different rout of administration and having a capability to deliver hydrophobic and hydrophilic drug molecules. This review focuses on type, preparation and evaluation of nanoparticles.
Downloads
References
4. Vyas SP, Khar RK, Targeted and controlled drug delivery: Novel carrier systems CBS Publishers, New Delhi, 2002; Page no 26-39.
5. Chen Y. in vitro characterization and in vivo evaluation of microsphere as carriers for the anticancer drug adriamycin. Ph.D thesis 1989, University of strathclyde Glasgow.
6. Allen TM, Cullis PR. Drug delivery systems: entering the mainstream. Science 2004; 303(5665):1818-1822.
7. Pignatello R, Bucolo C, Ferrara P, Maltese A, Puleo A, Puglisi G. Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen. Eur J Pharm Sci. 2002; 16(1-2):53-61.
8. Singh Davinder, Harikumar S L, Nirmala , Nanoparticles: An Overview , 2013, 3(2), 169-175 .
9. Klaus T., Joerger R., Olsson E. and Granqvist C.G., Silver Based Crystalline Nanoparticles, Microbially Fabricated, J. Proc. Natl. Acad. Sci. USA, 96, 13611-13614, (1999) .
10. Konishi Y. and Uruga T., Bioreductive Deposition of Platinum Nanoparticles on the Bacterium Shewanella algae, J. Biotechnol., 128, 648-653, (2007).
11. Willner I., Baron R. and Willner B., Growing metal nanoparticles by enzymes, J. Adv. Mater, 18, 1109-1120, (2006).
12. Vigneshwaran N., Ashtaputre N.M., Varadarajan P.V, Nachane R.P., Paralikar K.M., Balasubramanya R.H., Materials Letters, 61(6), 1413-1418, (2007).
13. Shankar S.S., Ahmed A., Akkamwar B., Sastry M., Rai A., Singh A. Biological synthesis of triangular gold nanoprism, Nature, 3 482, (2004).
14. Ahmad N., Sharma S., Singh V.N.,. Shamsi S.F, Fatma A. and Mehta B.R., Biosynthesis of silver nanoparticles from Desmodium triflorum : a novel approach towards weed utilization, Biotechnol. Res. Int . 454090 (1-8),(2011).
15. Govindaraju K, et al. Extra-cellular synthesis of silver nanoparticles by a marine alga, sargassum wightii grevilli and their antibacterial effects. J Nanosci Nanotechnol 2009; 9:5497-5501.
16. Bhainsa KC and D'souza S. Extracellular biosynthesis of silver nanopar-ticles using the fungus aspergillus fumigatus, Colloid Surfaces B 2006;47:160-164.
17. Chen J, et al. Evidence of the production of silver nanoparticles via pretreatment of phoma sp. 3.2883 with silver nitrate. Lett Appl Microbiol 2003;37:105-108.
18. Fayaz M, et al. Blue orange light emission from biogenic synthesized silver nanoparticles using tri-choderma viride, Colloid and Surfaces B 2010;75:175-178.
19. Narayanan KB and Sakthivel N. Facile green synthesis of gold nanos-tructures by NADPH-dependent enzyme from the extract of sclerotium rolfsii, Colloids and Surfaces A 2011;380:156-161.
20. Bharde A, et al. Extracellular biosynthesis of magnetite using fungi. Small 2006;2:135-141.
21. Nair LS and Laurencin CT. Silver nanoparticles: synthesis and therapeutic applications. J Biomed Nanotechnol 2007;3:301-316.
22. Mohanty S, et al. An investigation on the antibacterial, cytotoxic, and antibiofilm efficacy of starch-stabilized silver nanoparticles. Nanomedicine 2012;8:916-924.
23. Vigneshwaran N, et al. A novel one-pot green synthesis of stable silver nanoparticles using soluble starch. Carbohyd Res 2006;341:2012-2018.
24. Tran HV, et al. Synthesis, characterization, antibacterial and antiproliferative activities of monodisperse chitosan-based silver nanoparticles. Colloid Surface A 2010;360:32-40. 22. Gils PS, et al. Designing of silver nanoparticles in gum arabic based semi-ipn hydrogel. Int J Biol Macromol 2010;46:237-244.
25. Kora AJ, et al. Gum kondagogu (cochlospermum gossypium): a template for the green synthesis and stabilization of silver nanoparticles with antibacterial application, Carbohyd Polym 2010;82:670-679.
26. Quelemes PV, et al. Development and antibacterial activity of cashew gum-based silver nanoparticles. Int J Mol Sci 2013;14:4969-4981.
27. Venkatpurwar V and Pokharkar V. Green synthesis of silver nanoparticles using marine polysaccharide: Study of in-vitro antibacterial activity. Mater Lett 2011;65:999-1002.
28. Schrofel A, et al. Biosynthesis of gold nanoparticles using diatomssilica-gold and eps-gold bionanocomposite formation. J Nanoparticle Res 2011;13:3207-3216.
29. Dameron C, etal. Biosynthesis of cadmium sulphide quantum semiconductor crystallites. Nature 1989;338:596.
30. Dameron, C.T.; Reese, R.N.; Mehra, R.K.; Kortan, A.R.; Carroll, P.J.; Steigerwald, M.L.; Brus, L.E.; Winge, D.R. Biosynthesis of cadmium sulphide quantum semiconductor crystallites. Nature 1989, 338, 596–597.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright © Author(s) retain the copyright of this article.

.